Search Saint Luke's

Advanced Solid Tumors

First-in-Human Study of STX-478, a H1047X Mutation-specific PI3Kα Inhibitor as Monotherapy and in Combination with Other Antineoplastic Agents in Advanced Solid Tumor Patients Tumors

2026 Race Date Coming Soon

Women's Cardiovascular Health
Pregnancy Complications Leading to Cardiovascular Disease Outcomes Registry

After getting COVID-19, Laura became seriously ill in a matter of days. Read her inspiring story of survival after spending weeks hooked up to a ventilator, fighting for her life.

After noticing a lump her breast, Laura was diagnosed with breast cancer just nine weeks into her pregnancy with her second child.

Whether you're visiting a Saint Luke's facility in-person or conducting a virtual visit, we want to make sure you have all the information you'll need.

We are honored you have chosen Saint Luke’s for your health care needs. Please review the following information to help prepare for your hospital stay.

Julie Quirin, FACHE, retiring after nearly 30 years of service with Saint Luke’s.

Jani Johnson retiring after 40 years of service with Saint Luke’s

Coronary Artery Disease
A randomized controlled study of the Prevail Drug-Coated Balloon in subjects with in-stent restenosis and a single arm prospectively enrolled study of the Prevail Drug-Coated Balloon for de novo lesions in small vessel disease (Prevail Global)